Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-31 Sale | 2026-01-02 4:19 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 6,552 | $23.38 | $153,186 | 67,924 (Direct) | View |
| 2025-12-16 Sale | 2025-12-18 5:35 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 12,662 | $22.01 | $278,739 | 74,476 (Direct) | View |
| 2025-11-26 Sale | 2025-11-26 4:07 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 5,000 | $25 | $125,000 | 87,138 (Direct) | View |
| 2025-10-28 Sale | 2025-10-29 08:54 am | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 5,000 | $20 | $100,000 | 92,138 (Direct) | View |
| 2024-12-31 Sale | 2025-01-03 4:08 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 3,594 | $15 | $53,910 | 60,138 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 5:23 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 2,004 | $20 | $40,080 | 51,831 (Direct) | View |
| 2023-12-18 Sale | 2023-12-20 4:10 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 5,557 | $17.92 | $99,564 | 53,835 (Direct) | View |
| 2023-06-07 Sale | 2023-06-09 4:05 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 4,049 | $20.04 | $81,142 | 59,392 (Direct) | View |
| 2022-12-16 Sale | 2022-12-16 9:44 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 2,453 | $30.75 | $75,430 | 11,566 (Direct) | View |
| 2021-12-16 Sale | 2021-12-20 4:22 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 1,106 | $40.12 | $44,376 | 7,019 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-23 Option Award | 2025-01-27 4:30 pm | N/A 2025-01-22 | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 187,000 | $0 | 247,138 (Direct) | View |
| 2024-12-15 Tax Withholding | 2024-12-17 8:36 pm | N/A N/A | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 10,099 | $16.08 | 63,732 (Direct) | View |
| 2024-01-23 Option Award(A) | 2024-02-23 5:49 pm | N/A N/A | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 22,000 | $0 | 73,831 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 7:40 pm | N/A 2034-01-22 | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 107,900 | $0 | 159,731 (Direct) | View |
| 2023-01-23 Option Award | 2023-01-25 5:53 pm | N/A 2033-01-22 | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 172,200 | $0 | 201,641 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-10 5:08 pm | N/A 2032-03-07 | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 78,000 | $0 | 85,019 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-20 4:10 pm | N/A 2031-01-18 | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 87,500 | $0 | 92,500 (Direct) | View |